ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度持续督导现场培训工作报告 | 2025-04-20 | Chinese | |
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度持续督导工作现场检查报告 | 2025-04-20 | Chinese | |
| 2024年度独立董事述职报告（张勇） | 2025-04-20 | Chinese | |
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度募集资金存放与实际使用情况专项核查报告 | 2025-04-20 | Chinese | |
| 2024年年度审计报告 | 2025-04-20 | Chinese | |
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司使用部分暂时闲置募集资金和自有资金进行现金管理的核查意见 | 2025-04-20 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44579688 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度持续督导现场培训工作报告 | 2025-04-20 | Chinese | ||
| 44579679 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度持续督导工作现场检查报告 | 2025-04-20 | Chinese | ||
| 44579666 | 2024年度独立董事述职报告（张勇） | 2025-04-20 | Chinese | ||
| 44579656 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度募集资金存放与实际使用情况专项核查报告 | 2025-04-20 | Chinese | ||
| 44579650 | 2024年年度审计报告 | 2025-04-20 | Chinese | ||
| 44579596 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司使用部分暂时闲置募集资金和自有资金进行现金管理的核查意见 | 2025-04-20 | Chinese | ||
| 44579587 | 关于提请股东大会授权董事会办理以简易程序向特定对象发行股票相关事宜的公告 | 2025-04-20 | Chinese | ||
| 44579581 | 董事会决议公告 | 2025-04-20 | Chinese | ||
| 44579575 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司2024年度内部控制评价报告的核查意见 | 2025-04-20 | Chinese | ||
| 44579570 | 关于2024年度利润分配预案的公告 | 2025-04-20 | Chinese | ||
| 44579557 | 关于举行2024年度网上业绩说明会的公告 | 2025-04-20 | Chinese | ||
| 44579550 | 内部控制审计报告 | 2025-04-20 | Chinese | ||
| 44579423 | 关于召开2024年年度股东大会的通知 | 2025-04-20 | Chinese | ||
| 44579416 | 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-04-20 | Chinese | ||
| 44579413 | 关于2024年度计提资产减值损失和信用减值损失的公告 | 2025-04-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.